CTRI/2009/091/000562已完成4 期
Real life Effectiveness of Symbicort Maintenance and Reliever Therapy (SMART) in Asthma Patients across Asia: SMARTASIA
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 162
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Provision of signed informed consent.
- •- Asthma diagnosis at least 6 months before visit 1 of study
- •- Patients who have reversible airway obstruction continuous asthma treatment except Symbicort at least within 4 weeks before visit 1 of study
排除标准
- •- Known or suspected allergy to active ingredients of study medication or excipients
- •- Use of oral, rectal or parenteral glucocorticosteroids 30 days before visit 1 of study
- •- Smoking, current or previous with a smoking history of ≥10 pack years
研究者
相似试验
进行中（未招募）
不适用
A comparison of Symbicort® Maintenance and Reliever Therapy (Symbicort Turbuhaler® 160/4.5 mg, one inhalation bid plus as-needed) and Symbicort Turbuhaler 160/4.5 mg, one inhalation bid plus terbutaline Turbuhaler 0.4 mg/inhalation as needed, for treatment of asthma – a 12-month, randomized, double-blind, parallel group, active-controlled, multinational phase III study in asthmatic patients aged 16 years and above. - SAKURAAsthmaEUCTR2008-006869-86-HUAstraZeneca AB2,400
已完成
3 期
A comparative study of Symbicort® Maintenance and Reliever Therapy (Symbicort Turbuhaler® 160/4.5 mg, one inhalation bid plus as-needed) and Symbicort Turbuhaler 160/4.5 mg, one inhalation bid plus Terbutaline Turbuhaler 0.4 mg/inhalation as-needed, for treatment of asthma.CTRI/2009/091/000240AstraZeneca R D249
已完成
4 期
Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across AsiaAsthmaNCT00939341AstraZeneca862
进行中（未招募）
不适用
A comparison of the efficacy of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 microg, one inhalation twice a day plus as-needed) and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults. A randomised, open, parallel-group, multicentre, 26 weeks study - MONOEUCTR2004-000679-32-FIAstraZeneca Oy1,900
招募中
不适用
Evaluation of the efficacy of Symbicort turbuhaler that target patients with bronchial ashtma complicated by COPD and bronchial asthma - Evaluation of diurnal variation in peak flowbronchial asthma complicated by COPD and bronchial ashtmaJPRN-UMIN000007708Department of respirology, graduate School of Medicine, Chiba University100